{"id":3478,"date":"2024-09-09T18:48:09","date_gmt":"2024-09-09T18:48:09","guid":{"rendered":"https:\/\/oshot.info\/members\/?p=3478"},"modified":"2026-10-14T19:32:55","modified_gmt":"2026-10-14T19:32:55","slug":"jcpm2024-09-03-female-sexual-function-index-fsfi","status":"publish","type":"post","link":"https:\/\/oshot.info\/members\/jcpm2024-09-03-female-sexual-function-index-fsfi\/","title":{"rendered":"JCPM2024.09.03 | Female Sexual Function Index | FSFI |"},"content":{"rendered":"<div>\n<table class=\"c32\">\n<tbody>\n<tr class=\"c22\">\n<td class=\"c17\" colspan=\"1\" rowspan=\"1\">\n<p class=\"c2\"><span class=\"c38\">Journal Club with Pearls &amp; Marketing 2024.09.03 \u00a0 \u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/&amp;sa=D&amp;source=editors&amp;ust=1725910150576267&amp;usg=AOvVaw2QgUN4l0Qw9uiUbma9mSy0\" target=\"_blank\" rel=\"noopener\">Cellular Medicine Association<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h1 class=\"c9 title\"><span class=\"c26\" style=\"color: #0000ff;\">JCPM2024.09.03<\/span><\/h1>\n<p class=\"c27\"><span class=\"c28 c36\">The following is an edited transcript of the<span>\u00a0<\/span><\/span><span class=\"c1\">Journal Club with Pearls &amp; Marketing<\/span><span class=\"c5\">\u00a0(JCPM) of September 3, 2024, with Charles Runels, MD. \u00a0<\/span><\/p>\n<p class=\"c27\"><span class=\"c7 c28\"><a class=\"c20\" href=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/09\/JCPM2024.09.03-pdf-edited.pdf\" target=\"_blank\" rel=\"noopener\">&gt;-&gt; The pdf of the transcript of this live journal club can be seen here &lt;-&lt;<\/a><\/span><\/p>\n<div style=\"padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%;\" title=\"JCPM2023.09.03 Female Sexual Function Index | FSFI | Clitoxin\u00ae | O-Shot\u00ae\" src=\"https:\/\/player.vimeo.com\/video\/1006858371?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\" frameborder=\"0\"><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Topics Covered<\/span><\/h1>\n<ul class=\"c31 lst-kix_list_11-0 start\">\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Female Sexual Distress Scale-Revised (FSDS-R)<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Female Sexual Function Index (FSFI)<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Quick overview of the O-Shot\u00ae provider membership site<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Reasons for administering the FSFI for every O-Shot\u00ae recipient<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">What you must learn from magicians to do good medicine<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">New Metanalysis, Knee injections: HA vs. Steroids vs. PRP<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Female Sexual Function Index (FSFI) research<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">My Gift to You: Software to Quickly Administer and Grade the FSFI of Your Patients<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c6\">Scenario One for administering the FSFI with the Free Software: Patient in the Office<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c6\">Scenario Two for administering the FSFI with the Free Software: Patient Not in the Office<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Using the FSFI as an Educational Marketing Tool (to help you find the women you could help)<\/span><\/strong><\/span><\/li>\n<li class=\"c16 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Marketing Idea Using the FSFI Tool<\/span><\/strong><\/span><\/li>\n<li class=\"c2 c35 li-bullet-0\"><span style=\"color: #800080;\"><strong><span class=\"c12\">Should you add Exosomes to your O-Shot\u00ae?<\/span><\/strong><\/span><\/li>\n<\/ul>\n<figure id=\"attachment_2007\" aria-describedby=\"caption-attachment-2007\" style=\"width: 300px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-2007 size-medium\" src=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/03\/image12-300x239.jpg\" alt=\"\" width=\"300\" height=\"239\" \/><figcaption id=\"caption-attachment-2007\" class=\"wp-caption-text\">Charles Runels, MD<\/figcaption><\/figure>\n<p class=\"c24\"><span class=\"c29 c40\">Charles Runels, MD<br \/>\nAuthor, researcher, and inventor of the Vampire Facelift\u00ae, Orchid Shot\u00ae (O-Shot\u00ae), Priapus Shot\u00ae (P-Shot\u00ae), Priapus Toxin\u00ae, Vampire Breast Lift\u00ae, and Vampire Wing Lift\u00ae, &amp; Clitoxin\u00ae procedures.<\/span><\/p>\n<h1 class=\"c9 title\"><span class=\"c26\" style=\"color: #800080;\">Transcript<\/span><\/h1>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Female Sexual Distress Scale<\/span><\/h1>\n<p class=\"c2\"><span>If you read the research about female sexual function, you see two surveys being used primarily. One is the Female Sexual Distress Scale, which we're looking at now (see video).<\/span><sup class=\"c15\"><a id=\"ftnt_ref1\" href=\"#ftnt1\">[1]<\/a><\/sup><\/p>\n<p class=\"c2\"><span class=\"c0\">It's the easiest to do because you quickly add it up, and they're all scored the same, same domains for each question: never, rarely, occasionally, frequently, or always.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">The patient can breeze through it very quickly.<\/span><\/p>\n<p class=\"c2\"><span class=\"c18\">If the total score is less than 11, they're not distressed.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Remember, by definition, not matter what the symptoms, unless the woman is distress by those symptoms, she does not suffer sexual dysfunction.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">We have a HIPPA-compliant online survey your patients can do by text message (see the membership site on the dashboard).<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Female Sexual Function Index<\/span><\/h1>\n<p class=\"c2\"><span class=\"c0\">But if you look at the hardcore research, there seems to be a favoring towards the Female Sexual Function Index, which has 19 questions. Not only are the questions weighted differently, but then, to complicate it even more, you have to multiply the answers by a factor to come up with a score. It's not graduate-level calculus, but it's more time-consuming than the FSDS-R.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, I have a solution for you that I'm going to give you today. If you're doing the P-Shot\u00ae, you should be doing the SHIM score. It's easy\u2014it's so easy. It's five questions graded one through five, and patients just breeze through it. I have it on a piece of paper, they do it, and the score goes in my chart, which is on paper. If you're doing electronic records, you could still do that very quickly.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">But for this one (FSFI), it's aggravating. I found a place online that was grading it or that would grade it for you, but I didn't like it because it was full of ads and distracting and just not convenient in a couple of other ways. So, I had someone write some software for us, and I'll show you; it's free for you to use and for your patients to use. I'll show you where to get it in just a moment.<\/span><\/p>\n<p class=\"c2 subtitle\"><span class=\"c3\">First, here\u2019s a quick overview of our O-Shot\u00ae membership site:<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">After you log in, go to the dashboard. If you're new to the O-Shot\u00ae, hopefully, you're methodically moving through the course. Just take it a step at a time. And when you're done, you will know how to do the O-Shot\u00ae procedure. Each step is easy. There are a lot of steps, but it's stuff like, here's where to put your picture on the website, so it's not that big a deal if you are already a licensed doctor or physician extender and understand the anatomy.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">When you're finished, you know how to do the procedure.<\/span><\/p>\n<p class=\"c23\"><span class=\"c18\">With the FSDS-R, a higher number means more distress (bad);<br \/>\nwith the FSFI, a higher number means better function (good).<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Then, take the course on how to do the Clitoxin\u00ae procedure, which is an O-Shot\u00ae, as your base knowledge. After learning how to do the O-Shot\u00ae, you can simply add botulinum toxin to a portion of your O-Shot\u00ae procedure.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">If you're like me, you can't resist moving around the material. And after you've been through the courses, you need a reference. So, here's the material in the course (plus more) divided up in an organized way for you to go look for it as if in a filing cabinet.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">But there's a lot of stuff there. Most of our Journal Clubs can be searched. We now have over 800 videos and millions (literally) of words of content. So, if you get confused, you can always call our office (1-888-920-5311), but the search bar is a good place to go if you have a complicated question.<\/span><\/p>\n<p class=\"c2 subtitle\"><span class=\"c3\">Reasons for administering the FSFI for every O-Shot\u00ae recipient (what to learn from magicians)<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">When people come back and say, \"Well, I'm a little bit better, but I'm not sure, maybe I am, maybe I'm not,\" Sometimes documenting helps clarify the results.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">As a kid, I studied magic just like a lot of doctors. We grew up wanting to do miracles, and it's the best you can do is a magic trick as a kid. And if you're a magician, you know, you must slow down. I don't care if you make an elephant disappear; you must slow down and let people appreciate the magic or they will quite literally not notice that you just made an elephant disappear. If you move too fast, they don't even recognize what happened.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">In cosmetic work, being a magician means that you have before and after pictures or you do one side of the face, and you let them look at the other before you do that. Or if you're doing our Vampire Wing Lift\u00ae procedure, you do one labia majora, then you hand them the mirror and let them see that before you do the other. But with the sexual function, there's not a physical mirror to look at.<\/span><\/p>\n<p><a href=\"https:\/\/www.on2url.com\/app\/adtrack.asp?MerchantID=153781&amp;AdID=1012867\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-2754 size-full\" src=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/09\/image2.jpg\" alt=\"\" width=\"351\" height=\"499\" \/><\/a><\/p>\n<p class=\"c2\"><span class=\"c0\">But these surveys can help you quantify, and sometimes, just by having done this, you will point out to the person that they are indeed better when they may not have realized that they are. And especially with females, the Female Sexual Function Index gives a more granular look. So, if you're on the dashboard, here's where you click to get to it (see video).<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Here is a very detailed history and physical form (see video), but for a detailed questionnaire that can help you think a lot about your people, it is 18 pages of mostly yes-no questions.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">When you go here, it takes you to this page (see video). Some of this is redundant, but you'll see right here is the Female Sexual Function Index (FSFI) questionnaire. You can print that off if you want, but let's go over it. If you want to do it this way on paper, you could and then grade it by hand.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Let's look at the grading system, and then let me show you where I had some software installed so that you don't have to grade it.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Yes, I still recommend that you do this before every O-Shot\u00ae and then on follow-up. I'm about to show you how to administer the survey remotely\u2014by cell phone.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">New Metanalysis, Knee injections: HA vs. Steroids vs. PRP<\/span><\/h1>\n<p class=\"c2\"><span class=\"c0\">All right, so let me show you some of the research, and then I'll show you the software.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Okay, before I finish regarding FSFI, I had one paper out in our area of focus (cellular medicine) this week that I thought was worth bringing up. There were a lot more papers, three out this week, about using PRP to help improve fertility by improving the health of the endometrium. This is somewhat redundant too, but we've looked at a lot of the individual papers; this was a strong meta-analysis that confirmed what we've been talking about for literally years on our Journal Club, which is that with a knee injection, corticosteroids, HA and PRP are about the same when it comes to pain relief short term. In some studies, corticosteroids may win short-term for pain relief. But long-term, hands down, the PRP beats HA and corticosteroids for pain and preservation of the knee.<\/span><\/p>\n<p class=\"c23\"><span class=\"c18\">Long-term, hands down, the PRP beats HA and corticosteroids for pain and preservation of the knee.<\/span><\/p>\n<p class=\"c2\"><span>So, I'll give you a link to this one, too, and I won't go into the details.<\/span><sup class=\"c15\"><a id=\"ftnt_ref2\" href=\"#ftnt2\">[2]<\/a><\/sup><span>\u00a0<\/span><sup class=\"c15\"><a id=\"ftnt_ref3\" href=\"#ftnt3\">[3]<\/a><\/sup><span>\u00a0<\/span><sup class=\"c15\"><a id=\"ftnt_ref4\" href=\"#ftnt4\">[4]<\/a><\/sup><span>\u00a0<\/span><sup class=\"c15\"><a id=\"ftnt_ref5\" href=\"#ftnt5\">[5]<\/a><\/sup><\/p>\n<p class=\"c2\"><span>We've looked at most of the studies in this paper in previous Journal Clubs, but I wanted you to confirm that nothing has changed, and this meta-analysis supports what we've been talking about.<\/span><sup class=\"c15\"><a id=\"ftnt_ref6\" href=\"#ftnt6\">[6]<\/a><\/sup><span class=\"c0\">\u00a0<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">If you inject knees, this would be a great paper to share with your people. If this is something you want to do. I'll just put it in the chat box. If you open that up, you'll have it available.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, just a quick email or social media post says, \"Hey, we're still doing this. And if you're taking your weight loss medicine and you want to keep it off, you need to be walking. And if your knees are a problem, here's confirmation that yes, a year from now, if you use PRP, you will have less degeneration of your joint and less pain than if you get the 25-cent corticosteroid shot that your insurance company wants you to have.\u201d<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Okay, so that's the only new paper I thought out this week that I found to be worth sending out to your patients.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Female Sexual Function Index (FSFI) Research<\/span><\/h1>\n<p class=\"c2\"><span>Here's some of the research regarding the Female Sexual Function Index.<\/span><sup class=\"c15\"><a id=\"ftnt_ref7\" href=\"#ftnt7\">[7]<\/a><\/sup><span>\u00a0<\/span><sup class=\"c15\"><a id=\"ftnt_ref8\" href=\"#ftnt8\">[8]<\/a><\/sup><\/p>\n<p class=\"c2\"><span class=\"c0\">That's the test. 19 questions, and the questions are different. And then look how you score it.<span>\u00a0<\/span><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-2753 alignleft\" src=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/09\/image3-1024x397.png\" alt=\"\" width=\"640\" height=\"248\" \/><\/p>\n<p class=\"c2\"><span class=\"c0\">Not what you want to calculate when you are busy talking with one of your patients (and do you really want to score this after you see the patient or have the results immediately available to discuss with the woman in front of you?\\<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, questions one and two are the desired domain. For the desire domain, you multiply the total score by 0.6,<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Questions 17, 18, and 19 are pain; you score those by multiplying the individual question scores by 0.4.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">\u00a0You can see the scoring for each domain is different too. Sometimes it's one through five, sometimes it's zero through five, but you take those and multiply it by 0.4.<\/span><\/p>\n<p class=\"c2\"><span>But the fun thing is you wind up getting a very helpful score for each domain and a total score; it's fun because the scores\u00a0<\/span><span class=\"c19 c29\">are<\/span><span class=\"c0\">\u00a0helpful. The FSFI can be more informative than just, \"Am I distressed or not?\" (the FSDS-R score)<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I think it helps to know, in the total scheme of things, whether this person is upset or not because that's the definition of sexual dysfunction.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">If they're not more than an 11 on a Female Sexual Distress Scale, even if they have other things that are bothering them continually, by definition, by that strictest of definitions, they don't have female sexual dysfunction.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">You can see that manually scoring the FSFI is not something you want to do when you're 30 minutes behind on your schedule and you have two patients waiting.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">What do you do?<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">My Gift to You: Software to Quickly Administer and Grade the FSFI of Your Patients<\/span><\/h1>\n<p class=\"c2\"><span class=\"c0\">If you're taking care of women, I hope this becomes not only a time saver but a way to quantify better what you're doing.<\/span><\/p>\n<p class=\"c2\"><span>If you look at that paper my wife Alex and I just published, we only reported that the Female Sexual Function Index improved in all domains after\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/clitoxin.com\/&amp;sa=D&amp;source=editors&amp;ust=1725910150559890&amp;usg=AOvVaw15Le88zqR3EqdGWcv_hARc\" target=\"_blank\" rel=\"noopener\">Clitoxin\u00ae<\/a><\/span><span>\u00a0(except pain was not as good). The total and the individual domain scores went crazy, better than FDA-approved drugs on the market (and better than the off-label therapies, too).<\/span><sup class=\"c15\"><a id=\"ftnt_ref9\" href=\"#ftnt9\">[9]<\/a><\/sup><span>\u00a0<\/span><sup class=\"c15\"><a id=\"ftnt_ref10\" href=\"#ftnt10\">[10]<\/a><\/sup><\/p>\n<p class=\"c2\"><span>If you look at the original article we published about the O-Shot\u00ae,<\/span><sup class=\"c15\"><a id=\"ftnt_ref11\" href=\"#ftnt11\">[11]<\/a><\/sup><span class=\"c0\">\u00a0we did both Female Sexual Distress and Female Sexual Function Index.<\/span><\/p>\n<p class=\"c2\"><span>Hold on a second. I want you to have this because this is the classic paper on the FSFI test. Okay, there it is. It's in your handout section if you want to download it. This by Rosen, came out 24 years ago. It talks about the Female Sexual Distress, Female Sexual Function Index, and how they came to depend on it.<\/span><sup class=\"c15\"><a id=\"ftnt_ref12\" href=\"#ftnt12\">[12]<\/a><\/sup><\/p>\n<p class=\"c2\"><span class=\"c0\">Okay, let me show you the software I made for you, and then hopefully you can teach me something, or if you have any questions, I'll answer them, and we'll call it a night.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I'll probably wind up putting this in other places, but I have it in an easy-to-remember domain.<\/span><\/p>\n<p class=\"c2 subtitle\"><span class=\"c3\">Scenario One for administering the FSFI with the Free Software: Patient in the Office<\/span><\/p>\n<p class=\"c2\"><span>One scenario might be that you could text this link to your patient before they come to the office, or you could have an iPad where they and you pull up\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/oshot.info\/members\/fsfi\/&amp;sa=D&amp;source=editors&amp;ust=1725910150561120&amp;usg=AOvVaw1fPGgKfGGxt-CWe1OEmKcd\">this webpage<\/a><\/span><span class=\"c0\">\u00a0at the office and have someone fill it out.<\/span><\/p>\n<p class=\"c2\"><span>I don't know about you, but sometimes, just something that takes an extra five minutes for me, I won't do it if I'm in the middle of seeing patients. If you go to\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/oshot.info\/members\/fsfi\/&amp;sa=D&amp;source=editors&amp;ust=1725910150561504&amp;usg=AOvVaw0EN5f9zfaebb6lLwDEuV9J\">oshot.info\/members\/fsfi<\/a><\/span><span class=\"c0\">, all are in lowercase; it is not password protected. I don't want you to fiddle with passwords while seeing patients.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">There is nothing for sale, no ads, and nothing to buy. It is not password-protected.<\/span><\/p>\n<p class=\"c2 subtitle\"><span class=\"c3\">Scenario Two for administering the FSFI with the Free Software: Patient Not in the Office<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Another scenario is (since it works on a cell phone), you could text the link to them they could fill it out on their cell phone at home and text you a screenshot of the score (they could also fill it out on their cell phone while they're sitting there waiting for their blood to spin, getting ready to do your O-Shot\u00ae or Clitoxin\u00ae procedure.<\/span><\/p>\n<p class=\"c2\"><span>So\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/oshot.info\/members\/fsfi\/&amp;sa=D&amp;source=editors&amp;ust=1725910150562031&amp;usg=AOvVaw0OPdwCxLAfq7_ZXKjUlj1_\">there are the instructions (see the web page)<\/a><\/span><span class=\"c0\">.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Thought about leaving the instructions out: Do we really need to tell people that stimulation includes foreplay with a partner, masturbation, or fantasy? I don't know, but I put that there. Bill Clinton had trouble figuring it out, so maybe our patients will, too.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, we define sex right there (for our patients and for Bill Clinton). And then you see, I've already taken the test to check it. If they needed to retake it, they just clicked the \u201cretake test\u201d hyperlink, and then the quiz restarted.<\/span><\/p>\n<p class=\"c2 subtitle\"><span class=\"c3\">Demonstration of the Software<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I will randomly pick answers and go through it so you can see what happens.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">This is the same scoring system and set of questions as the one in that PDF file I showed you. Because your patients are not members of our provider group, a lot of what you see over here that's for our \u201cmembers only\u201d is not going to show up; it's just going to be mostly the test. Some of it will, but everything that might show up would reconfirm the validity of what you're doing.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">19 questions. It is such a hassle to grade this thing by hand.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Okay. Using the software, you then submit the answers, and boom, you have it.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, if they were sitting in the office, you could have them take a screenshot of that result and text it to you (to click and drag into their EMR), or you could scratch down the domain scores into your paper chart. In this demonstration, you can see the desire score was 3.6. Those are your scores for each of the domains and there's the total score.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">You can also see their answers to each of the questions.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">The few places I've found a way to grade FSFI online that would do this for me were distracting and pestering me with ads.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">It took a couple of months, but I hired someone to write this software for us.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">And this is a present to you.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Using the FSFI as an Educational Marketing Tool (to help you find the women you could help)<\/span><\/h1>\n<p class=\"c2\"><span class=\"c0\">This electronic FSFI could also be used as a marketing tool.<\/span><\/p>\n<p class=\"c2\"><span>For example, you could have a webpage that talks about female sexual dysfunction and female sexual normal function. If you put that same link in there,\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/oshot.info\/members\/fsfi&amp;sa=D&amp;source=editors&amp;ust=1725910150563240&amp;usg=AOvVaw2ofFjXQSz1xhIbTwkd2nKa\">oshot.info\/members\/fsfi<\/a><\/span><span class=\"c0\">, in lower case, if you put that link into a text message or on a web page or a social media post, then people could go to the survey and find out how they compare and if they could use your help.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">And if you told them on your web page or on our social media post that anything less than 20 is the average of most women who complain about their sex and most women having good sex are over 30 or more, then they're going to wonder, \"Well, where am I?\"<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">They could do this and then have objective numbers to facilitate their decision and discussions with their spouse about whether to see you.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">You will think of 16 other ways to use this tool.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I'll put it in the chat box, answer your questions, and call it a night.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">As I said, this took some time, and it wasn't like coding the space launch or something, but it took a couple of months, and I hope you guys find it worth using.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Questions<\/span><\/h1>\n<h2 class=\"c2\"><span class=\"c0\" style=\"color: #800080;\">Does it give the patient a report analysis?<\/span><\/h2>\n<p class=\"c2\"><span class=\"c0\">Yep. It gives them a chart of the different domains with their scores.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Let's see, where was that? It gives them that but doesn't give them anything more detailed.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Hopefully, it will make them curious about how you can help them and want to have a conversation with you about how to improve things.<\/span><\/p>\n<h2 class=\"c2 subtitle\"><span class=\"c3\" style=\"color: #800080;\">The Orgasm System<\/span><\/h2>\n<p class=\"c2\"><span>Remember, it's\u00a0<\/span><span class=\"c19 c29\">a system<\/span><span>. I still don't hear many people using this word, but I hope we start to talk more and more about the\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/orgasmcollege.com\/femaleorgasmsystem\/&amp;sa=D&amp;source=editors&amp;ust=1725910150564289&amp;usg=AOvVaw3RsFGEG4HU7oXvgKB4RO43\" target=\"_blank\" rel=\"noopener\">female orgasm system<\/a><\/span><span class=\"c0\">.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">\u00a0For sex to work properly, to work very well, everything in that picture needs to be working.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Let's pick something. Pelvic floor muscles are not working right. They're in pain. You've got dyspareunia, labia, you lichen sclerosus; you've got pain, your hood's phimosed, or you've had genital mutilation. You pick anything on there. Any one of those hormones makes any one of those things go wrong, and you're going to have trouble with sex.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, what I hope happens is when these domains come up like that, you can say, \"Yeah, we got the O-Shot\u00ae that can help with lubrication, but for arousal, you might also need some testosterone. Maybe we need some counseling, sexual counseling,\" like that, it prompts a conversation.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">It's not an AI sort of app where it tries to take your place and have that conversation instead of you doing it.<\/span><\/p>\n<h2 class=\"c2\"><span class=\"c0\" style=\"color: #800080;\">Pete says I have a quick question. Let's see. \u201cAre there contraindications P-Shot\u00ae?<\/span><\/h2>\n<p class=\"c2\"><span class=\"c0\">The basic rule I follow is, could this person have surgery, and could they have an injection?<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Could have surgery and still be able to heal?<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">For example, if they have high-dose corticosteroids, I wouldn't do it because they're not going to heal well.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">If they can have a shot, though, if someone's on an anticoagulant, for example, you may not want to do intra-abdominal surgery, but you can give them an injection.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So those are the basic rules I follow. If someone has factor V deficiency, the question is, could you give them an injection?<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">You might want to go easy on the pump (it would increase bruising in this case); I'll sometimes do that. But as a rule, if they can have an injection and they can heal the wound, I'll do a P-Shot\u00ae.<\/span><\/p>\n<p class=\"c2\"><span>If you go to the\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/clitoxin.com\/research&amp;sa=D&amp;source=editors&amp;ust=1725910150565398&amp;usg=AOvVaw249IRhJQZKfN6a8SYIyvwU\" target=\"_blank\" rel=\"noopener\">Clitoxin\u00ae page<\/a><\/span><span>\u00a0and look at the\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/www.longdom.org\/open-access\/the-clitoral-injection-of-incobotulinumtoxina-for-the-improvement-of-arousal-orgasm-sexual-satisfaction-a-specific-method-and-the--106601.html&amp;sa=D&amp;source=editors&amp;ust=1725910150565753&amp;usg=AOvVaw0Q2CZ5MRJ5CrpDRhcXDHwW\" target=\"_blank\" rel=\"noopener\">research we just published here<\/a><\/span><span>, the results are framed in terms of the Female Sexual Function Index and how it improves with each.<\/span><sup class=\"c15\"><a id=\"ftnt_ref13\" href=\"#ftnt13\">[13]<\/a><\/sup><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-2008 alignleft\" src=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/03\/image2-300x188.jpg\" alt=\"\" width=\"300\" height=\"188\" \/><\/p>\n<p class=\"c2\"><span>My wife (<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/thescarlettphoenix.com\/about-dr-alex-runnels\/&amp;sa=D&amp;source=editors&amp;ust=1725910150566246&amp;usg=AOvVaw15sb25ixSXE1hfBdspMZ5W\" target=\"_blank\" rel=\"noopener\">Alexandra Runnels, MD, FACOG<\/a><\/span><span class=\"c0\">), my co-author, did this math. The Female Sexual Index total changed by eight with the botulinum toxin alone and by 12 when we added the PRP.<span>\u00a0<\/span><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-2752 size-large\" src=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/09\/image1-1024x574.png\" alt=\"\" width=\"640\" height=\"359\" \/><\/p>\n<p class=\"c2\"><span>Flibanserin and bremelanotide, two drugs that are FDA-approved for female sexual dysfunction, barely beat the placebo in a meta-analysis that looked at placebo across multiple studies.<\/span><sup class=\"c15\"><a id=\"ftnt_ref14\" href=\"#ftnt14\">[14]<\/a><\/sup><span class=\"c0\">\u00a0<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So, when talking to women about their FSFI scores, you get to integrate what's possible (and what\u2019s not possible) because of what we're doing.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">There's a reason not to teach too much online: I want them to come to you for a more accurate assessment. If you feel like I should add more, maybe we can.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Marketing Idea using the FSFI Tool<\/span><\/h1>\n<p class=\"c2\"><span class=\"c0\">But if you want to discuss the details further, you could create your own webpage. Put a link to the one I just gave you on your page, and then have your video or whatever you want to say about the test right there (see video), and send your people to your page.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">So let's see if I can find something. I think I did something like that or started it on the Clitoxin\u00ae page, but I haven't finished it yet.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">But see, it's just a link. This is clitoxin.com Female Sexual Function Index. I built this today, and it just got the link, but I'm giving you a demonstration. I can have your video that talks about Clitoxin\u00ae research, and this is what it did. If you want to see more, go here to see the research.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">But if you want to see how you fall into that scale, click here.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">And then when they do, boom, they're back taking the test. Okay. Let's see what other questions we have.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">And I think that's, I know, in my case, the main reason for not doing the Female Sexual Function Index, both as a document and as an education tool, documenting results before and after, educating people about where they might be about their sisters, about what the research says: it's just a time factor. But now, if I can click something and say to them, \"Please, fill that out on your iPhone while I'm spinning your blood,\" it makes life much easier.<\/span><\/p>\n<h2 class=\"c2 subtitle\"><span class=\"c3\" style=\"color: #800080;\">Are you using Exosomes in your O-Shot procedure?<\/span><\/h2>\n<p class=\"c2\"><span class=\"c0\">All right, I think there were a couple of other questions.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I'm not using exosomes yet. The best I can tell is that if you do exosomes, you can't talk about it because the FDA doesn't like it yet.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I know people are doing it. I'm not telling you not to do it, I'm just saying I don't do it. We've gotten great results without it and all the research we've done.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Salespeople (and some providers) will say, \"If you're over 60, your PRP doesn't work.\"<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">My answer to that is, \u201cWell, you can have surgery over 60, and my skin still heals, and things still work, so I'd rather not have to think about the FDA knocking on my door.\u201d<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">But I know I'm old school. So, I don't do stem cells, exosomes, amnion, or anything else that is a dog whistle for the FDA to visit me. I stopped when the FDA started cracking skulls and taking people to jail.<\/span><\/p>\n<p class=\"c2\"><span>There's a\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=http:\/\/cellularmedicineassociation.org\/fda\/&amp;sa=D&amp;source=editors&amp;ust=1725910150567801&amp;usg=AOvVaw2eMgqM8sswQaEnqN7GH0Kg\" target=\"_blank\" rel=\"noopener\">website where the FDA tells patients what to ask when they're in your office<\/a><\/span><span class=\"c0\">\u00a0getting stem cells or exosomes.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">They give them a script, saying, \"Can you show me the institutional review board study that you're involved in while doing this therapy?\"<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Thousands are doing it, but I've had three-letter people knock on my door (FDA, IRS, DEA, FBI); it's not fun. So, I don't do anything I can't talk about on the billboard.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">Okay, I hope that's helpful to you guys. Thank you for being on the call.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">I'll tweak where our new FSFI tool lives and probably put it in different places on the O-Shot\u00ae website, and you guys can run with it. It's yours to use however you wish.<\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">You all have a good night.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">References<\/span><\/h1>\n<p class=\"c2 c13\"><span class=\"c0\">Belk, John W., Darby A. Houck, Connor P. Littlefield, Matthew J. Kraeutler, Andrew G. Potyk, Omer Mei-Dan, Jason L. Dragoo, Rachel M. Frank, and Eric C. McCarty. \u201cPlatelet-Rich Plasma versus Hyaluronic Acid for Hip Osteoarthritis Yield Similarly Beneficial Short-Term Clinical Outcomes: A Systematic Review and Meta-Analysis of Level I and II Randomized Controlled Trials.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">Arthroscopy<\/span><span class=\"c0\">\u00a00, no. 0 (November 13, 2021). https:\/\/doi.org\/10.1016\/j.arthro.2021.11.005.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Bensa, Alessandro, Alessandro Sangiorgio, Angelo Boffa, Manuela Salerno, Giacomo Moraca, and Giuseppe Filardo. \u201cCorticosteroid Injections for Knee Osteoarthritis Offer Clinical Benefits Similar to Hyaluronic Acid and Lower than Platelet-Rich Plasma: A Systematic Review and Meta-Analysis,\u201d September 1, 2024. https:\/\/doi.org\/10.1530\/EOR-23-0198.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Cole, Brian J., Vasili Karas, Kristen Hussey, David B. Merkow, Kyle Pilz, and Lisa A. Fortier. \u201cHyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-Articular Biology for the Treatment of Knee Osteoarthritis.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">The American Journal of Sports Medicine<\/span><span class=\"c0\">\u00a045, no. 2 (February 21, 2017): 339\u201346. https:\/\/doi.org\/10.1177\/0363546516665809.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">DeRogatis, Leonard, Anita Clayton, Diane Lewis-D\u2019Agostino, Glen Wunderlich, and Yali Fu. \u201cValidation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire Disorder.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">The Journal of Sexual Medicine<\/span><span class=\"c0\">\u00a05, no. 2 (February 1, 2008): 357\u201364. https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00672.x.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Idres, Fatima A, and Michel Samaan. \u201cIntra-Articular Platelet-Rich Plasma vs. Corticosteroid Injections Ef\ufb01cacy in Knee Osteoarthritis Treatment: A Systematic Review,\u201d 2023.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Peng, Yu-Ning, Jean-Lon Chen, Chih-Chin Hsu, Carl P. C. Chen, and Areerat Suputtitada. \u201cIntra-Articular Leukocyte-Rich Platelet-Rich Plasma versus Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Meta-Analysis of 14 Randomized Controlled Trials.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">Pharmaceuticals<\/span><span class=\"c0\">\u00a015, no. 8 (August 7, 2022): 974. https:\/\/doi.org\/10.3390\/ph15080974.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">\u201cResearch \u2013 Clitoxin\u00ae.\u201d Accessed September 9, 2024. https:\/\/clitoxin.com\/research\/.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Rosen, R., C. Brown, and J. Heiman. \u201cThe Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">J Sex Marital Ther<\/span><span class=\"c0\">\u00a026 (2000). https:\/\/doi.org\/10.1080\/009262300278597.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Runels, Charles. \u201cA Pilot Study of the Effect of Localized Injections of Autologous Platelet Rich Plasma (PRP) for the Treatment of Female Sexual Dysfunction.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">Journal of Women\u2019s Health Care<\/span><span class=\"c0\">\u00a003, no. 04 (2014). https:\/\/doi.org\/10.4172\/2167-0420.1000169.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Runels, Charles, and Alexandra Runnels. \u201cThe Clitoral Injection of IncobotulinumtoxinA for the Improvement of Arousal, Orgasm &amp; Sexual Satisfaction- A Specific Method and the Effects on Women.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">Journal of Women\u2019s Health Care<\/span><span class=\"c0\">\u00a013, no. 3 No. 715 (March 20, 2024). https:\/\/doi.org\/10.35248\/2167-0420.24.13.715.<\/span><\/p>\n<p class=\"c2 c13\"><span class=\"c0\">Wiegel, Markus, Cindy Meston, and Raymond Rosen. \u201cThe Female Sexual Function Index (FSFI): Cross-Validation and Development of Clinical Cutoff Scores.\u201d<span>\u00a0<\/span><\/span><span class=\"c4\">Journal of Sex &amp; Marital Therapy<\/span><span class=\"c0\">\u00a031, no. 1 (January 2005): 1\u201320. https:\/\/doi.org\/10.1080\/00926230590475206.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\">Tags<\/span><\/h1>\n<p class=\"c2\"><span class=\"c0\">Female Sexual Function, Female Sexual Distress Scale, Female Sexual Function Index, O-Shot\u00ae, P-Shot\u00ae, SHIM score, Clitoxin\u00ae, botulinum toxin, PRP, fertility, endometrium, corticosteroids, HA, pain relief, knee injection, meta-analysis, journal club, sexual dysfunction, female orgasm, dyspareunia, lichen sclerosus, sexual counseling, testosterone, Vampire Wing Lift\u00ae, before-and-after pictures, electronic records, software, research, patient surveys, sex hormones, FDA compliance, exosomes, stem cells, amnion.<\/span><\/p>\n<h1 class=\"c14\"><span class=\"c21\" style=\"color: #0000ff;\">Helpful Links<\/span><\/h1>\n<p class=\"c2\"><span>=&gt;\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/accma.memberlodge.org\/page-925782&amp;sa=D&amp;source=editors&amp;ust=1725910150570582&amp;usg=AOvVaw1ZfcljO-t5OMeg-ORvzLlD\" target=\"_blank\" rel=\"noopener\">Next Hands-On Workshops with Live Models<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<p class=\"c2\"><span>=&gt;\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/www.on2url.com\/app\/adtrack.asp?MerchantID%3D153781%26AdID%3D1012867&amp;sa=D&amp;source=editors&amp;ust=1725910150570946&amp;usg=AOvVaw2NwtERN8XhazUWBEqg0sub\" target=\"_blank\" rel=\"noopener\">Dr. Runels<span>\u00a0<\/span><\/a><\/span><span class=\"c7 c19\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/www.on2url.com\/app\/adtrack.asp?MerchantID%3D153781%26AdID%3D1012867&amp;sa=D&amp;source=editors&amp;ust=1725910150571139&amp;usg=AOvVaw3pnHQ1WGgFxlUFpahFqAuv\" target=\"_blank\" rel=\"noopener\">Botulinum Blastoff Course<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<p class=\"c2\"><span>=&gt;\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/oshot.info\/members\/fsfi\/&amp;sa=D&amp;source=editors&amp;ust=1725910150571459&amp;usg=AOvVaw3utq_Dkz1dVDNb0OxKQKN1\">FSFI Online Administrator and Calculator<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<p class=\"c2\"><span>=&gt;\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/&amp;sa=D&amp;source=editors&amp;ust=1725910150571795&amp;usg=AOvVaw36BbzZXix_jLv1WQU7MtSX\" target=\"_blank\" rel=\"noopener\">The Cellular Medicine Association (CMA): Who we are<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<p class=\"c2\"><span>=&gt;<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/procedures\/&amp;sa=D&amp;source=editors&amp;ust=1725910150572059&amp;usg=AOvVaw0dsIyCWsqIuyF7SaUy_LLP\" target=\"_blank\" rel=\"noopener\">\u00a0Apply for<span>\u00a0<\/span><\/a><\/span><span class=\"c7 c19\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/procedures\/&amp;sa=D&amp;source=editors&amp;ust=1725910150572241&amp;usg=AOvVaw1xFG8kALtFGZvAF8hZ01-R\" target=\"_blank\" rel=\"noopener\">Online Training for Multiple PRP Procedures<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<p class=\"c2\"><span>=&gt;<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/password\/&amp;sa=D&amp;source=editors&amp;ust=1725910150572576&amp;usg=AOvVaw0wsB7OdZ2xNUGxSd7vzSgj\" target=\"_blank\" rel=\"noopener\">\u00a0Help with<span>\u00a0<\/span><\/a><\/span><span class=\"c7 c19\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/password\/&amp;sa=D&amp;source=editors&amp;ust=1725910150572771&amp;usg=AOvVaw0yk5XS5d4koxf_paQSzqnt\" target=\"_blank\" rel=\"noopener\">Logging into Membership Website<\/a><\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/cellularmedicineassociation.org\/password\/&amp;sa=D&amp;source=editors&amp;ust=1725910150572927&amp;usg=AOvVaw2GwDPGI5hHgGnsvDht_QXN\" target=\"_blank\" rel=\"noopener\">s<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<p class=\"c2\"><span>=&gt;\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/ontraport.com\/Cellular-Medicine-Association-&amp;sa=D&amp;source=editors&amp;ust=1725910150573274&amp;usg=AOvVaw3qz3h8G7-vfc6OS7GwQAV3\" target=\"_blank\" rel=\"noopener\">The software I use to send emails: ONTRAPORT (free trial)<\/a><\/span><span class=\"c7\">\u00a0&lt;=<\/span><span class=\"c0\">\u00a0<\/span><\/p>\n<p class=\"c2\"><span>=&gt; Sell O-Shot\u00ae products: You make 10% with links you place; shipped by the manufacturer),\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/www.loom.com\/share\/dcd9fe2284a746a199fd7d5cc42d5f61?sid%3Df5a33b4b-a3ee-4fb1-b13e-2273718dce9b&amp;sa=D&amp;source=editors&amp;ust=1725910150573663&amp;usg=AOvVaw1NEg4UfDcmqNZreNKZtfPp\" target=\"_blank\" rel=\"noopener\">this explains<\/a><\/span><span>\u00a0and\u00a0<\/span><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/oshotwomen.leaddyno.com\/&amp;sa=D&amp;source=editors&amp;ust=1725910150573907&amp;usg=AOvVaw3bfUREZ1Ovgh5321GkizLv\" target=\"_blank\" rel=\"noopener\">here\u2019s where to apply<\/a><\/span><span class=\"c0\">\u00a0&lt;=<\/span><\/p>\n<div>\n<table class=\"c32\">\n<tbody>\n<tr class=\"c22\">\n<td class=\"c34\" colspan=\"1\" rowspan=\"1\">\n<p class=\"c2\"><span class=\"c7\"><a class=\"c20\" href=\"https:\/\/www.google.com\/url?q=https:\/\/runels.com\/&amp;sa=D&amp;source=editors&amp;ust=1725910150577325&amp;usg=AOvVaw1OFJLXwg3_gdXttOTgHWkj\" target=\"_blank\" rel=\"noopener\">Charles Runels, MD<\/a><\/span><\/p>\n<p class=\"c2\"><span class=\"c0\">1-888-920-5311<\/span><\/p>\n<\/td>\n<td class=\"c25\" colspan=\"1\" rowspan=\"1\">\n<p class=\"c11\"><span>Page\u00a0<\/span><span>\u00a0of<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<hr class=\"c33\" \/>\n<div>\n<p class=\"c2\"><a id=\"ftnt1\" href=\"#ftnt_ref1\">[1]<\/a><span class=\"c10\">\u00a0DeRogatis et al., \u201cValidation of the Female Sexual Distress Scale-Revised for Assessing Distress in Women with Hypoactive Sexual Desire Disorder.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt2\" href=\"#ftnt_ref2\">[2]<\/a><span class=\"c10\">\u00a0Bensa et al., \u201cCorticosteroid Injections for Knee Osteoarthritis Offer Clinical Benefits Similar to Hyaluronic Acid and Lower than Platelet-Rich Plasma.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt3\" href=\"#ftnt_ref3\">[3]<\/a><span class=\"c10\">\u00a0Peng et al., \u201cIntra-Articular Leukocyte-Rich Platelet-Rich Plasma versus Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt4\" href=\"#ftnt_ref4\">[4]<\/a><span class=\"c10\">\u00a0Belk et al., \u201cPlatelet-Rich Plasma versus Hyaluronic Acid for Hip Osteoarthritis Yield Similarly Beneficial Short-Term Clinical Outcomes.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt5\" href=\"#ftnt_ref5\">[5]<\/a><span class=\"c10\">\u00a0Cole et al., \u201cHyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-Articular Biology for the Treatment of Knee Osteoarthritis.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt6\" href=\"#ftnt_ref6\">[6]<\/a><span class=\"c10\">\u00a0Idres and Samaan, \u201cIntra-Articular Platelet-Rich Plasma vs. Corticosteroid Injections Ef\ufb01cacy in Knee Osteoarthritis Treatment: A Systematic Review.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt7\" href=\"#ftnt_ref7\">[7]<\/a><span class=\"c10\">\u00a0Wiegel, Meston, and Rosen, \u201cThe Female Sexual Function Index (FSFI).\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt8\" href=\"#ftnt_ref8\">[8]<\/a><span class=\"c10\">\u00a0Rosen, Brown, and Heiman, \u201cThe Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt9\" href=\"#ftnt_ref9\">[9]<\/a><span class=\"c10\">\u00a0Runels and Runnels, \u201cThe Clitoral Injection of IncobotulinumtoxinA for the Improvement of Arousal, Orgasm &amp; Sexual Satisfaction- A Specific Method and the Effects on Women.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt10\" href=\"#ftnt_ref10\">[10]<\/a><span class=\"c10\">\u00a0\u201cResearch \u2013 Clitoxin\u00ae.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt11\" href=\"#ftnt_ref11\">[11]<\/a><span class=\"c10\">\u00a0Runels, \u201cA Pilot Study of the Effect of Localized Injections of Autologous Platelet Rich Plasma (PRP) for the Treatment of Female Sexual Dysfunction.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt12\" href=\"#ftnt_ref12\">[12]<\/a><span class=\"c10\">\u00a0Rosen, Brown, and Heiman, \u201cThe Female Sexual Function Index (FSFI): A Multidimensional Self-Report Instrument for the Assessment of Female Sexual Function.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt13\" href=\"#ftnt_ref13\">[13]<\/a><span class=\"c10\">\u00a0Runels and Runnels, \u201cThe Clitoral Injection of IncobotulinumtoxinA for the Improvement of Arousal, Orgasm &amp; Sexual Satisfaction- A Specific Method and the Effects on Women.\u201d<\/span><\/p>\n<\/div>\n<div>\n<p class=\"c2\"><a id=\"ftnt14\" href=\"#ftnt_ref14\">[14]<\/a><span class=\"c10\">\u00a0Runels and Runnels.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Journal Club with Pearls &amp; Marketing 2024.09.03 \u00a0 \u00a0Cellular Medicine Association JCPM2024.09.03 The following is an edited transcript of the\u00a0Journal Club with Pearls &amp; Marketing\u00a0(JCPM) of September 3, 2024, with Charles Runels, MD. \u00a0 &gt;-&gt; The pdf of the transcript of this live journal club can be seen here &lt;-&lt; Topics Covered Female Sexual Distress [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[1311,47,141],"tags":[311,594,89,221,704,16,40,68,138,973,20,916,25],"class_list":["post-3478","post","type-post","status-publish","format-standard","hentry","category-botulinum-toxin","category-journal-club","category-o-shot","tag-botulinum-toxin","tag-clitoxin","tag-dyspareunia","tag-erectile-dysfunction","tag-female-sexual-dysfunction","tag-lichen-sclerosus","tag-o-shot","tag-priapus-shot","tag-prp","tag-regenerative-medicine","tag-research","tag-testosterone","tag-vampire-wing-lift"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6W8NG-U6","jetpack-related-posts":[{"id":5159,"url":"https:\/\/oshot.info\/members\/jcpm2026-07-07-priapus-toxin-p-shot-alopecia-areata-blindness-ozempic-vulva\/","url_meta":{"origin":3478,"position":0},"title":"JCPM2026.07.07 | Priapus Toxin\u00ae + P-Shot\u00ae | Alopecia Areata &#038; Blindness | Ozempic Vulva","author":"Charles Runels, MD","date":"July 8, 2026","format":false,"excerpt":"Journal Club with Pearls & Marketing 2026.07.07 Cellular Medicine Association JCPM2026.07.07 The following is an edited transcript of the Journal Club with Pearls & Marketing (JCPM) of July 7, 2026, with Charles Runels, MD. >-> The PDF of this live journal club can be seen here <-< Topics Covered Opening\u2026","rel":"","context":"In &quot;Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)&quot;","block_context":{"text":"Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)","link":"https:\/\/oshot.info\/members\/category\/botulinum-toxin\/"},"img":{"alt_text":"","src":"data:image\/jpeg;base64,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","width":350,"height":200},"classes":[]},{"id":5153,"url":"https:\/\/oshot.info\/members\/jcpm2026-06-23-female-ejaculation-clitoxin-priapus-toxin-alopecia\/","url_meta":{"origin":3478,"position":1},"title":"JCPM2026.06.23 | Female Ejaculation | Clitoxin\u00ae | Priapus Toxin\u00ae | Alopecia","author":"Charles Runels, MD","date":"July 1, 2026","format":false,"excerpt":"Journal Club with Pearls & Marketing 2026.06.23 Cellular Medicine Association JCPM2026.06.23 The following is an edited transcript of the Journal Club with Pearls & Marketing (JCPM) of June 23, 2026, with Charles Runels, MD. >-> The PDF of this live journal club can be seen here <-< Topics Covered PRP\u2026","rel":"","context":"In &quot;Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)&quot;","block_context":{"text":"Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)","link":"https:\/\/oshot.info\/members\/category\/botulinum-toxin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2880,"url":"https:\/\/oshot.info\/members\/jcpm2022-11-22video-bocoxwebsitefree2pshotprovidersmarketingplan\/","url_meta":{"origin":3478,"position":2},"title":"JCPM2022.11.22Video.BocoxWebSite(free2PShotProviders)MarketingPlan","author":"Charles Runels, MD","date":"November 23, 2022","format":false,"excerpt":"Topics *The new Bocox website and how to use it to find people who need your services (it is free for you to use if you are a P-Shot\u2122 provider) *What to do about refunds *Man with inverted penis post spinal cord injury *finding keywords that work Relevant Links BotoxPenis.com\u2026","rel":"","context":"In &quot;Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)&quot;","block_context":{"text":"Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)","link":"https:\/\/oshot.info\/members\/category\/botulinum-toxin\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":5219,"url":"https:\/\/oshot.info\/members\/jcpm2026-08-18-alopecia-areata-female-sexual-dysfunction-o-shot-procedure\/","url_meta":{"origin":3478,"position":3},"title":"JCPM2026.08.18 | Alopecia Areata | Female Sexual Dysfunction | O-Shot\u00ae Procedure","author":"Charles Runels, MD","date":"August 28, 2026","format":false,"excerpt":"JCPM2026.08.18 The following is an edited transcript of the Journal Club with Pearls & Marketing (JCPM) of August 18, 2026, with Charles Runels, MD. >-> The PDF transcript of this live journal club can be seen here <-< Topics Covered Revisiting a Study We Have Covered Before They Changed Where\u2026","rel":"","context":"In &quot;Aesthetics &amp; Hair&quot;","block_context":{"text":"Aesthetics &amp; Hair","link":"https:\/\/oshot.info\/members\/category\/aesthetics-hair\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":4941,"url":"https:\/\/oshot.info\/members\/jcpm2026-04-21-o-shot-in-l-d-for-episiotomy-hair-and-skin-cancer-glp-1-and-bedroom\/","url_meta":{"origin":3478,"position":4},"title":"JCPM2026.04.21 | O-Shot\u00ae in L &#038; D for Episiotomy | Hair and Skin Cancer | GLP-1 and Bedroom","author":"Charles Runels, MD","date":"May 14, 2026","format":false,"excerpt":"The following is an edited transcript of the Journal Club with Pearls & Marketing\u00a0(JCPM) of April 21, 2026, with Charles Runels, MD.\u00a0\u00a0 -> The PDF of this live journal club can be seen here <-< =>The marketing kit for this journal club is here (pre-written emails)<= Topics Covered PRP Variability\u2026","rel":"","context":"In &quot;Childbirth, Scars &amp; Trauma&quot;","block_context":{"text":"Childbirth, Scars &amp; Trauma","link":"https:\/\/oshot.info\/members\/category\/childbirth-scars-trauma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2025\/07\/image5-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":3271,"url":"https:\/\/oshot.info\/members\/jcpm2024-04-02-clitoxin-orphan-therapeutics\/","url_meta":{"origin":3478,"position":5},"title":"JCPM2024.04.02 | Clitoxin\u00ae | &#8220;Orphan Therapeutics&#8221;","author":"Charles Runels, MD","date":"April 7, 2024","format":false,"excerpt":"Journal Club with Pearls & Marketing 2024.04.02 \u00a0 \u00a0Cellular Medicine Association JCPM2024.04.02 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of April 2, 2024, with Charles Runels, MD, and Alexandra Runnels, MD, FACOG. >-> The PDF Transcript of the Page Can be Downloaded or Read\u2026","rel":"","context":"In &quot;Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)&quot;","block_context":{"text":"Botulinum Toxin (Clitoxin\u00ae, Priapus Toxin\u2122)","link":"https:\/\/oshot.info\/members\/category\/botulinum-toxin\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/03\/image12-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/3478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/comments?post=3478"}],"version-history":[{"count":2,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/3478\/revisions"}],"predecessor-version":[{"id":3480,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/3478\/revisions\/3480"}],"wp:attachment":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/media?parent=3478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/categories?post=3478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/tags?post=3478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}